Ö. Sonmez Et Al. , "Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?," Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.1185-9, 2015
Sonmez, Ö. Et Al. 2015. Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?. Asian Pacific journal of cancer prevention : APJCP , vol.16 , 1185-9.
Sonmez, Ö., Guclu, E., Uyeturk, U., Esbah, O., Turker, I., Bal, O., ... Budakoglu, B.(2015). Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?. Asian Pacific journal of cancer prevention : APJCP , vol.16, 1185-9.
Sonmez, ÖZLEM Et Al. "Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?," Asian Pacific journal of cancer prevention : APJCP , vol.16, 1185-9, 2015
Sonmez, ÖZLEM Et Al. "Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?." Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.1185-9, 2015
Sonmez, Ö. Et Al. (2015) . "Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?." Asian Pacific journal of cancer prevention : APJCP , vol.16, pp.1185-9.
@article{article, author={ÖZLEM SÖNMEZ Et Al. }, title={Which one is more effective, filgrastim or lenograstim, during febrile neutropenia attack in hospitalized patients with solid tumors?}, journal={Asian Pacific journal of cancer prevention : APJCP}, year=2015, pages={1185-9} }